← Leaderboards
Daniel Bryce Landi
Duke University
$696,098
Attributed
$1,392,196
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $697.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$1,392,196 · 1
By mechanism
R01$1,392,196 · 1
Top collaborators
- Eric Thompson3 shared
Grant awards (3)
Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma$358,401
R01 · FY2025 · FD · contact PI
Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma$336,734
R01 · FY2024 · FD · contact PI
Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma$697,061
R01 · FY2021 · FD · contact PI